Kavar Capital Partners Group’s Pediatrix Medical MD Stock Holding History

Kavar Capital Partners Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-20	Closed	-$1K	–	313
2014 Q1	$1K	Hold	20	–	–	﹤0.01%	455
2013 Q4	$1K	Buy	+20	New	+$1.07K	﹤0.01%	429

Other funds holding MD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kavar Capital Partners Group's MD Position: Q2 2014 in Review

Kavar Capital Partners Group sold out of Pediatrix Medical (MD) in Q2 2014, closing a stake of 20 shares — an estimated $1K sold.

Kavar Capital Partners Group first reported a position in MD in Q4 2013 and held it in 2 quarters. The position peaked at $1K in Q1 2014. 334 funds tracked by Wall St. Rank hold MD as of Q2 2014.

Kavar Capital Partners Group reported no remaining Pediatrix Medical position as of Q2 2014 after selling out during the quarter.
Kavar Capital Partners Group sold 20 Pediatrix Medical shares in Q2 2014, an estimated $1K.
Kavar Capital Partners Group first reported a position in Pediatrix Medical in Q4 2013 and held it in 2 quarters.
Kavar Capital Partners Group's Pediatrix Medical position peaked at $1K in Q1 2014.
334 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2014.

Based on Kavar Capital Partners Group's 13F filing for Q2 2014, filed 25 Jan 2019.